✨ Your Portfolio is fetched and updated from zerodha.
Small
Market Cap
₹7,495 Cr.
P/E
27.85

Key Ratios

Market cap
Market cap
7,495 Cr
PE
PE
27.85
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
11.96
ROCE (%)
ROCE (%)
12.02
Div Yield (%)
Div Yield (%)
-
Sales
Sales
2,118 Cr
OPM (%)
OPM (%)
14.69 %
Debt to Equity
Debt to Equity
-
About
FDC is in the Miscellaneous sector with a M.cap of 7495.00 Cr and a PE ratio of 27.85.
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on FDC Ltd. Business

FDC Limited is a renowned pharmaceutical company in India, established in 1936. It focuses on producing top-notch products such as Oral Rehydration Salts (ORS) and prescription formulations with internationally accredited manufacturing units.

FDC major competitors are Marksans Pharma, Strides Pharma Scien, Procter&Gamble Healt, Sequent Scientific, Guj. Themis Biosyn, Orchid Pharma, Gufic Biosciences.
Market Cap of FDC is ₹7,440 Crs.
While the median market cap of its peers are ₹4,263 Crs.

FDC seems to be less financially stable compared to its competitors.
Altman Z score of FDC is 5.13 and is ranked 6 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Aug Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
Investor Presentation Sep Mar May Jun Aug Sep Dec Sep Mar Mar Sep
Conference Call Sep Mar Jun Sep Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material